» Articles » PMID: 28954391

Neuron-Glia Crosstalk and Neuropathic Pain: Involvement in the Modulation of Motor Activity in the Orofacial Region

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2017 Sep 29
PMID 28954391
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Neuropathic orofacial pain (NOP) is a debilitating condition. Although the pathophysiology remains unclear, accumulating evidence suggests the involvement of multiple mechanisms in the development of neuropathic pain. Recently, glial cells have been shown to play a key pathogenetic role. Nerve injury leads to an immune response near the site of injury. Satellite glial cells are activated in the peripheral ganglia. Various neural and immune mediators, released at the central terminals of primary afferents, lead to the sensitization of postsynaptic neurons and the activation of glia. The activated glia, in turn, release pro-inflammatory factors, further sensitizing the neurons, and resulting in central sensitization. Recently, we observed the involvement of glia in the alteration of orofacial motor activity in NOP. Microglia and astroglia were activated in the trigeminal sensory and motor nuclei, in parallel with altered motor functions and a decreased pain threshold. A microglial blocker attenuated the reduction in pain threshold, reduced the number of activated microglia, and restored motor activity. We also found an involvement of the astroglial glutamate-glutamine shuttle in the trigeminal motor nucleus in the alteration of the jaw reflex. Neuron-glia crosstalk thus plays an important role in the development of pain and altered motor activity in NOP.

Citing Articles

Early prevention of carrageenan-induced peripheral/spinal inflammation suppresses microglial hyperreactivity in the trigeminal spinal subnucleus caudalis and alleviates chronic facial nociception.

Yamamoto T, Yoshida M, Koyama Y, Mulpuri Y, Imado E, Oue K Heliyon. 2025; 11(2):e41602.

PMID: 39897904 PMC: 11782953. DOI: 10.1016/j.heliyon.2024.e41602.


Involvement of sphingosine-1-phosphate receptor 1 in pain insensitivity in a BTBR mouse model of autism spectrum disorder.

Fan L, Li Q, Shi Y, Li X, Liu Y, Chen J BMC Med. 2024; 22(1):504.

PMID: 39497100 PMC: 11533282. DOI: 10.1186/s12916-024-03722-3.


Activating transcription factor 3 (ATF3) and calcitonin gene-related peptide (CGRP) increase in trigeminal ganglion neurons in female rats after photorefractive keratectomy (PRK)-like corneal abrasion.

Gunter C, Jiang C, Zeimantz S, Hegarty D, Morgans C, Largent-Milnes T Neurobiol Pain. 2024; 16:100165.

PMID: 39315304 PMC: 11419808. DOI: 10.1016/j.ynpai.2024.100165.


The Role of PKM2 in Multiple Signaling Pathways Related to Neurological Diseases.

Zhang X, Lei Y, Zhou H, Liu H, Xu P Mol Neurobiol. 2023; 61(8):5002-5026.

PMID: 38157121 DOI: 10.1007/s12035-023-03901-y.


URB937 Prevents the Development of Mechanical Allodynia in Male Rats with Trigeminal Neuralgia.

Demartini C, Greco R, Zanaboni A, Francavilla M, Facchetti S, Tassorelli C Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004491 PMC: 10675761. DOI: 10.3390/ph16111626.


References
1.
Guo W, Wang H, Watanabe M, Shimizu K, Zou S, Lagraize S . Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci. 2007; 27(22):6006-18. PMC: 2676443. DOI: 10.1523/JNEUROSCI.0176-07.2007. View

2.
Renton T, Yilmaz Z . Profiling of patients presenting with posttraumatic neuropathy of the trigeminal nerve. J Orofac Pain. 2012; 25(4):333-44. View

3.
Ceruti S, Fumagalli M, Villa G, Verderio C, Abbracchio M . Purinoceptor-mediated calcium signaling in primary neuron-glia trigeminal cultures. Cell Calcium. 2007; 43(6):576-90. DOI: 10.1016/j.ceca.2007.10.003. View

4.
Wei F, Guo W, Zou S, Ren K, Dubner R . Supraspinal glial-neuronal interactions contribute to descending pain facilitation. J Neurosci. 2008; 28(42):10482-95. PMC: 2660868. DOI: 10.1523/JNEUROSCI.3593-08.2008. View

5.
Clark A, Yip P, Malcangio M . The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J Neurosci. 2009; 29(21):6945-54. PMC: 2698289. DOI: 10.1523/JNEUROSCI.0828-09.2009. View